Global and Regional Health Technology Assessment

Aims & Scope

Global Health & Technology Assessment (GRHTA) is an international, indexed, peer-reviewed, open access, online only journal, published once a year.

It aims to promote health technology assessment and economic evaluation, enabling choices among alternative therapeutical paths or procedures with different clinical and economic outcomes.

The Journal fosters a refined search of the relation between economic factors and decision-making in healthcare, based on the role of scientific and technological advancement in reaching higher healthcare standards and the intrinsic limitations within each market in allocating healthcare resources.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Plagiarism url
• Apc url

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,500.00 EUR. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Determining the value contribution of emicizumab (Hemlibra^®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

  Citation: 13

  Authors: Maria Teresa, Ignacio, Rafael, José Luís, José Antonio, Amparo, José Luís, Marina, Xavier

• The Feasibility Study: A Health Economics Perspective

  Citation: 11

  Authors: Brenda

• Cost-Effectiveness Evaluation of Oncological Drugs Newly Marketed in Italy

  Citation: 10

  Authors: Nicoletta, Carlo, Silvio, Valeria

• Cost Advantage of Fluocinolone Acetonide Implant (ILUVIEN®) versus Ranibizumab in the Treatment of Chronic Diabetic Macular Oedema

  Citation: 8

  Authors: Fahd, Annette

• Cost-effectiveness analysis of caplacizumab in the new standard of care for immune Thrombotic Thrombocytopenic Purpura in Italy

  Citation: 8

  Authors: Giovanni, Roberto

• Economic Analysis of the Immunostimulant OM-85 for the Prevention of Paediatric Recurrent Upper Respiratory Tract Infections

  Citation: 8

  Authors: Roberto

• When Simple Becomes Complicated: Why Excel Should Lose its Place at the Top Table

  Citation: 8

  Authors: Gianluca, Anna

• Cost-effectiveness of ponatinib in chronic myeloid leukemia in Italy

  Citation: 7

  Authors: Carlo, Sergio, Silvio, Giorgia, Silvia

• Social cost of chronic pain in Italy

  Citation: 7

  Authors: Massimo, Carlo, Silvio, Giulio

• The hospitalization burden of influenza: just the tip of the iceberg?

  Citation: 7

  Authors: Arianna, Giovanni, Fabrizio